Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Galapagos ( (NL:GLPG) ).
Galapagos NV disclosed that Bank of America Corporation has crossed the 5% threshold of voting rights in the company, as required under Belgian transparency rules. The move results from acquisitions of both direct voting rights and a substantial volume of equivalent financial instruments tied to Galapagos shares.
As of 11 February 2026, Bank of America and its subsidiaries together control 104,522 voting rights and 3,415,894 equivalent financial instruments, representing 5.34% of Galapagos’s outstanding shares. The increased exposure underscores growing institutional interest in the biopharmaceutical group and may be seen as a notable shift in its shareholder base, with implications for future engagement and market scrutiny.
The most recent analyst rating on (NL:GLPG) stock is a Hold with a EUR27.00 price target. To see the full list of analyst forecasts on Galapagos stock, see the NL:GLPG Stock Forecast page.
More about Galapagos
Galapagos NV is a Belgian biopharmaceutical company listed on Euronext and Nasdaq, focusing on the discovery, development and commercialization of innovative medicines. The company targets unmet medical needs, with a global investor base that closely tracks changes in its shareholder structure and voting rights. These ownership shifts can influence market perception and governance dynamics.
Average Trading Volume: 59,998
Technical Sentiment Signal: Hold
Current Market Cap: €1.87B
For an in-depth examination of GLPG stock, go to TipRanks’ Overview page.